Synergistic Peptide Combination for Comprehensive Repair Research
This research product combines two well-characterized peptides—BPC-157 (Body Protecting Compound-157) and TB-500 (Thymosin Beta-4 Acetate)—into a single, standardized blend for laboratory investigation. This combination allows researchers to study potential synergistic effects on tissue repair, as BPC-157 primarily influences systemic protective mechanisms and angiogenesis, while TB-500 focuses on cellular migration and actin cytoskeletal regulation. Supplied as a pre-mixed lyophilized powder containing precisely 2.5mg of each peptide per 5mg vial, this combined formulation is intended strictly for controlled, non-human laboratory research exploring combinatorial approaches to wound healing, musculoskeletal recovery, and inflammatory modulation in experimental models.
Complete Research Kit Contents & Verification
Each research order provides a complete experimental package designed for investigating combination peptide therapeutics:
-
Primary Research Compound: 10 sterile glass vials containing 5mg of lyophilized peptide blend per vial (2.5mg BPC-157 + 2.5mg TB-500 Acetate).
-
Reconstitution Solution: 30ml vial of sterile Bacteriostatic Water (0.9% Benzyl Alcohol), essential for creating stable peptide solutions for experimental use.
-
Laboratory Administration Tools: Pack of sterile 1ml insulin syringes (29G x 1/2″) for precise measurement and transfer in accordance with research protocols.
-
Sterilization Supplies: Individually wrapped alcohol prep swabs to maintain aseptic technique during vial handling and reconstitution.
-
Research Protocol Documentation:
-
Dosing Schedule: Standardized administration protocol for research models focusing on combined tissue repair, tendon/ligament healing studies, and anti-inflammatory research.
-
Usage Instructions: Comprehensive guide covering reconstitution math, storage conditions (-20°C recommended for both peptides), handling safety, and experimental design for combination therapy studies.
-
-
Quality Verification: Dual Certificate of Analysis (CoA) provided with each batch, detailing for EACH peptide component:
-
BPC-157 Component:
-
Purity Analysis (>98% by HPLC)
-
Sequence Verification (Mass Spectrometry)
-
Molecular Weight: 1419.56 Da Confirmed
-
-
TB-500 Component:
-
Purity Analysis (>98% by HPLC)
-
Sequence Verification (Mass Spectrometry)
-
Molecular Weight: 4963.5 Da (Acetate Salt) Confirmed
-
-
Blend Verification:
-
Precise 1:1 Ratio Confirmation (2.5mg ±0.1mg each)
-
Sterility Testing Results (Combined)
-
Endotoxin Levels (<10 EU/mg total)
-
Homogeneity Testing of Lyophilized Blend
-
-
Research Applications & Scientific Utility
In a laboratory setting, this combined peptide blend enables investigation into potentially synergistic repair mechanisms. Primary research applications include studying enhanced tendon-to-bone and ligament healing through combined angiogenic (BPC-157) and cellular migration (TB-500) effects, researching accelerated wound closure models, investigating comprehensive anti-inflammatory pathways affecting multiple cytokine systems, exploring gastrointestinal protection with enhanced systemic healing responses, and modeling complex tissue regeneration where multiple repair phases require coordination. This combination allows researchers to test the hypothesis that simultaneously targeting different stages of the healing cascade (early inflammation/angiogenesis and later cellular migration/remodeling) may produce superior outcomes in experimental repair models.
Laboratory Handling & Safety Protocol
-
Storage: Store unopened lyophilized peptide blend vials at -20°C or below. Both peptides in the blend are stable under these conditions. Reconstituted solutions should be aliquoted and stored at -20°C and used within a reasonable experimental timeframe to ensure integrity of both components.
-
Reconstitution: Must be performed under sterile laboratory conditions using the provided bacteriostatic water. The blend is designed for complete solubility. Swirl gently to dissolve.
-
Laboratory Safety: Standard personal protective equipment (PPE) including lab coat, nitrile gloves, and safety glasses must be worn. Follow institutional biosafety level (BSL) guidelines for handling combined biochemical reagents.
-
Documentation: The dual CoA is critical for research integrity. Researchers should document the use of this specific 1:1 ratio blend in their methodologies and cite the CoA in publications.
⚠️ Critical Compliance & Intended Use Disclaimer:
THIS PRODUCT IS SOLD FOR RESEARCH USE ONLY (RUO). NOT FOR HUMAN OR VETERINARY DIAGNOSTIC OR THERAPEUTIC USE.
-
Intended Use: This BPC-157 & TB-500 blend is supplied as a combined biochemical reagent for laboratory research purposes only. It is intended for use by qualified researchers in controlled settings studying combination approaches to tissue repair biology. The included “dosing schedule” refers to standardized research model administration protocols only.
-
Not for Human Consumption: Under no circumstances is this product intended for administration to humans or animals. It is not a drug, dietary supplement, or therapeutic blend. The provided syringes and supplies are for laboratory measurement and transfer only.
-
Regulatory Status: This product has not been evaluated or approved by the FDA or any other global health authority for the diagnosis, cure, mitigation, treatment, or prevention of any disease or injury. The combination of these peptides for any use is investigational.
-
Novel Combination: This specific 1:1 ratio blend represents a research formulation. Its effects are not fully characterized, even in preclinical models. Researchers assume responsibility for designing appropriate controls.
-
Researcher Responsibility: It is the sole responsibility of the purchasing individual/institution to ensure compliance with all regulations regarding the possession, use, and disposal of research peptides and to use this combination product only for legitimate, non-human research within approved ethical guidelines.





Reviews
There are no reviews yet.